Hisamitsu Pharmaceutical Co (TSE:4530) Other Long-Term Liabilities : 円4,389 Mil (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Other Long-Term Liabilities?

Hisamitsu Pharmaceutical Co's other long-term liabilities for the quarter that ended in Nov. 2023 was 円4,389 Mil.

Hisamitsu Pharmaceutical Co's quarterly other long-term liabilities increased from May. 2023 (円4,981 Mil) to Aug. 2023 (円6,384 Mil) but then declined from Aug. 2023 (円6,384 Mil) to Nov. 2023 (円4,389 Mil).

Hisamitsu Pharmaceutical Co's annual other long-term liabilities declined from Feb. 2022 (円6,512 Mil) to Feb. 2023 (円3,630 Mil) but then increased from Feb. 2023 (円3,630 Mil) to Feb. 2024 (円6,488 Mil).

Hisamitsu Pharmaceutical Co Other Long-Term Liabilities Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Other Long-Term Liabilities Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Other Long-Term Liabilities

Get a 7-Day Free Trial

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Hisamitsu Pharmaceutical Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Hisamitsu Pharmaceutical Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines